LI
Liminatus Pharma, Inc. Warrants
LIMNW · NASDAQ
$0.05 +0.00% (+$0.00)
1M -13.48%
Market Cap $1.31M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
46 /100
Fair P/B 4.36x
EV/EBITDA N/A
P/S N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 367.93%
Asset turnover 0.00x
ROIC 225.12%
Debt
10 /100
High Current ratio 1.12x
Int. coverage -164.56x
Debt/Equity 4.80x
Stability
37 /100
Moderate EPS volatility 79.63%
Profitable years 0
Beta 0.74x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LIMNW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Chris Kim
Employees
1
Headquarters
Cerritos